{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T18:47:12Z","timestamp":1793040432607,"version":"4.5.0"},"reference-count":43,"publisher":"American Medical Association (AMA)","issue":"18","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA"],"published-print":{"date-parts":[[2018,5,8]]},"DOI":"10.1001\/jama.2018.3710","type":"journal-article","created":{"date-parts":[[2018,5,8]],"date-time":"2018-05-08T12:45:59Z","timestamp":1525783559000},"page":"1901","source":"Crossref","is-referenced-by-count":1267,"title":["Screening for Prostate Cancer"],"prefix":"10.1001","volume":"319","author":[{"name":"US Preventive Services Task Force","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David C.","family":"Grossman","sequence":"additional","affiliation":[{"name":"Kaiser Permanente Washington Health Research Institute, Seattle"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan J.","family":"Curry","sequence":"additional","affiliation":[{"name":"University of Iowa, Iowa City"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas K.","family":"Owens","sequence":"additional","affiliation":[{"name":"Veterans Affairs Palo Alto Health Care System, Palo Alto, California"},{"name":"Stanford University, Stanford, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsten","family":"Bibbins-Domingo","sequence":"additional","affiliation":[{"name":"University of California, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron B.","family":"Caughey","sequence":"additional","affiliation":[{"name":"Oregon Health & Science University, Portland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karina W.","family":"Davidson","sequence":"additional","affiliation":[{"name":"Columbia University, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chyke A.","family":"Doubeni","sequence":"additional","affiliation":[{"name":"University of Pennsylvania, Philadelphia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Ebell","sequence":"additional","affiliation":[{"name":"University of Georgia, Athens"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"John W.","family":"Epling","sequence":"additional","affiliation":[{"name":"Virginia Tech Carilion School of Medicine, Roanoke"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex R.","family":"Kemper","sequence":"additional","affiliation":[{"name":"Nationwide Children\u2019s Hospital, Columbus, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex H.","family":"Krist","sequence":"additional","affiliation":[{"name":"Fairfax Family Practice Residency, Fairfax, Virginia"},{"name":"Virginia Commonwealth University, Richmond"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martha","family":"Kubik","sequence":"additional","affiliation":[{"name":"Temple University, Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Seth","family":"Landefeld","sequence":"additional","affiliation":[{"name":"University of Alabama at Birmingham"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol M.","family":"Mangione","sequence":"additional","affiliation":[{"name":"University of California, Los Angeles"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Silverstein","sequence":"additional","affiliation":[{"name":"Boston University, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa A.","family":"Simon","sequence":"additional","affiliation":[{"name":"Northwestern University, Evanston, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert L.","family":"Siu","sequence":"additional","affiliation":[{"name":"Icahn School of Medicine at Mount Sinai, New York, New York"},{"name":"James J. Peters Veterans Affairs Medical Center, Bronx, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chien-Wen","family":"Tseng","sequence":"additional","affiliation":[{"name":"University of Hawaii, Honolulu"},{"name":"Pacific Health Research and Education Institute, Honolulu, Hawaii"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"12","key":"jus180004r2","doi-asserted-by":"publisher","first-page":"2795","DOI":"10.1002\/ijc.v137.12","article-title":"The high prevalence of undiagnosed prostate cancer at autopsy: implications for epidemiology and treatment of prostate cancer in the prostate-specific antigen-era.","volume":"137","author":"Jahn","year":"2015","journal-title":"Int J Cancer"},{"key":"jus180004r4","article-title":"Prostate-specific antigen-based screening for prostate cancer: evidence report and systematic review for the US Preventive Services Task Force","author":"Fenton","journal-title":"JAMA"},{"issue":"18","key":"jus180004r5","doi-asserted-by":"publisher","first-page":"2698","DOI":"10.1016\/j.ejca.2011.06.055","article-title":"False-positive screening results in the European randomized study of screening for prostate cancer.","volume":"47","author":"Kilpel\u00e4inen","year":"2011","journal-title":"Eur J Cancer"},{"issue":"11","key":"jus180004r6","doi-asserted-by":"publisher","first-page":"e484","DOI":"10.1016\/S1470-2045(14)70211-6","article-title":"Prevention and early detection of prostate cancer.","volume":"15","author":"Cuzick","year":"2014","journal-title":"Lancet Oncol"},{"issue":"4","key":"jus180004r7","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1002\/cncr.v123.4","article-title":"Extended mortality results for prostate cancer screening in the PLCO trial with median follow-up of 15 years.","volume":"123","author":"Pinsky","year":"2017","journal-title":"Cancer"},{"issue":"9959","key":"jus180004r8","doi-asserted-by":"publisher","first-page":"2027","DOI":"10.1016\/S0140-6736(14)60525-0","article-title":"Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up.","volume":"384","author":"Schr\u00f6der","year":"2014","journal-title":"Lancet"},{"issue":"10","key":"jus180004r9","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1093\/jnci\/djt038","article-title":"Prostate cancer mortality in the Finnish randomized screening trial.","volume":"105","author":"Kilpel\u00e4inen","year":"2013","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"jus180004r10","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.eururo.2014.12.006","article-title":"Opportunistic testing versus organized prostate-specific antigen screening: outcome after 18 years in the G\u00f6teborg randomized population-based prostate cancer screening trial.","volume":"68","author":"Arnsrud Godtman","year":"2015","journal-title":"Eur Urol"},{"issue":"5","key":"jus180004r11","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.eururo.2012.05.068","article-title":"Screening for prostate cancer decreases the risk of developing metastatic disease: findings from the European Randomized Study of Screening for Prostate Cancer (ERSPC).","volume":"62","author":"Schr\u00f6der","year":"2012","journal-title":"Eur Urol"},{"issue":"9","key":"jus180004r12","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1001\/jama.2018.0154","article-title":"Effect of a low-intensity PSA-based screening intervention on prostate cancer mortality: the CAP randomized clinical trial.","volume":"319","author":"Martin","year":"2018","journal-title":"JAMA"},{"issue":"2","key":"jus180004r13","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1111\/bju.2014.113.issue-2","article-title":"Mortality and complications after prostate biopsy in the Prostate, Lung, Colorectal and Ovarian Cancer Screening (PLCO) trial.","volume":"113","author":"Pinsky","year":"2014","journal-title":"BJU Int"},{"issue":"15","key":"jus180004r15","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1056\/NEJMoa1606220","article-title":"10-year outcomes after monitoring, surgery, or radiotherapy for localized prostate cancer.","volume":"375","author":"Hamdy","year":"2016","journal-title":"N Engl J Med"},{"issue":"1","key":"jus180004r16","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1001\/jama.2015.6036","article-title":"Trends in management for patients with localized prostate cancer, 1990-2013.","volume":"314","author":"Cooperberg","year":"2015","journal-title":"JAMA"},{"issue":"13","key":"jus180004r17","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1056\/NEJMoa0810696","article-title":"Mortality results from a randomized prostate-cancer screening trial.","volume":"360","author":"Andriole","year":"2009","journal-title":"N Engl J Med"},{"issue":"2","key":"jus180004r18","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1056\/NEJM200007133430201","article-title":"Environmental and heritable factors in the causation of cancer\u2014analyses of cohorts of twins from Sweden, Denmark, and Finland.","volume":"343","author":"Lichtenstein","year":"2000","journal-title":"N Engl J Med"},{"issue":"9","key":"jus180004r19","doi-asserted-by":"publisher","first-page":"2172","DOI":"10.1002\/ijc.v136.9","article-title":"Family history in the Finnish prostate cancer screening trial.","volume":"136","author":"Saarim\u00e4ki","year":"2015","journal-title":"Int J Cancer"},{"issue":"1","key":"jus180004r21","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.juro.2014.07.085","article-title":"Impact of family history on prostate cancer mortality in white men undergoing prostate specific antigen based screening.","volume":"193","author":"Liss","year":"2015","journal-title":"J Urol"},{"issue":"9","key":"jus180004r23","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1002\/cncr.v122.9","article-title":"Annual Report to the Nation on the Status of Cancer, 1975-2012, featuring the increasing incidence of liver cancer.","volume":"122","author":"Ryerson","year":"2016","journal-title":"Cancer"},{"issue":"10","key":"jus180004r25","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1002\/ijc.24870","article-title":"The effect of study arm on prostate cancer treatment in the large screening trial ERSPC.","volume":"126","author":"Wolters","year":"2010","journal-title":"Int J Cancer"},{"issue":"4","key":"jus180004r26","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1177\/1740774510374091","article-title":"Assessing contamination and compliance in the prostate component of the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial.","volume":"7","author":"Pinsky","year":"2010","journal-title":"Clin Trials"},{"issue":"10","key":"jus180004r27","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1056\/NEJMoa1311593","article-title":"Radical prostatectomy or watchful waiting in early prostate cancer.","volume":"370","author":"Bill-Axelson","year":"2014","journal-title":"N Engl J Med"},{"issue":"3","key":"jus180004r28","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1056\/NEJMoa1113162","article-title":"Radical prostatectomy versus observation for localized prostate cancer.","volume":"367","author":"Wilt","year":"2012","journal-title":"N Engl J Med"},{"issue":"2","key":"jus180004r29","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1056\/NEJMoa1615869","article-title":"Follow-up of prostatectomy versus observation for early prostate cancer.","volume":"377","author":"Wilt","year":"2017","journal-title":"N Engl J Med"},{"key":"jus180004r30","doi-asserted-by":"publisher","first-page":"d7894","DOI":"10.1136\/bmj.d7894","article-title":"Short term outcomes of prostate biopsy in men tested for cancer by prostate specific antigen: prospective evaluation within ProtecT study.","volume":"344","author":"Rosario","year":"2012","journal-title":"BMJ"},{"issue":"10","key":"jus180004r31","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1001\/jamainternmed.2013.323","article-title":"Five-year downstream outcomes following prostate-specific antigen screening in older men.","volume":"173","author":"Walter","year":"2013","journal-title":"JAMA Intern Med"},{"issue":"5","key":"jus180004r32","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1016\/S0090-4295(02)01958-1","article-title":"Complication rates and risk factors of 5802 transrectal ultrasound-guided sextant biopsies of the prostate within a population-based screening program.","volume":"60","author":"Raaijmakers","year":"2002","journal-title":"Urology"},{"issue":"7","key":"jus180004r33","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1111\/j.1525-1497.2006.00464.x","article-title":"The impact of a suspicious prostate biopsy on patients\u2019 psychological, socio-behavioral, and medical care outcomes.","volume":"21","author":"Fowler","year":"2006","journal-title":"J Gen Intern Med"},{"issue":"4","key":"jus180004r34","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1111\/bju.2006.98.issue-4","article-title":"Measuring the psychosocial impact of population-based prostate-specific antigen testing for prostate cancer in the UK.","volume":"98","author":"Brindle","year":"2006","journal-title":"BJU Int"},{"issue":"2","key":"jus180004r35","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.urology.2006.09.059","article-title":"Health perceptions in patients who undergo screening and workup for prostate cancer.","volume":"69","author":"Katz","year":"2007","journal-title":"Urology"},{"issue":"15","key":"jus180004r36","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1056\/NEJMoa1606221","article-title":"Patient-reported outcomes after monitoring, surgery, or radiotherapy for prostate cancer.","volume":"375","author":"Donovan","year":"2016","journal-title":"N Engl J Med"},{"issue":"9","key":"jus180004r37","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/S1470-2045(11)70162-0","article-title":"Long-term quality-of-life outcomes after radical prostatectomy or watchful waiting: the Scandinavian Prostate Cancer Group-4 randomised trial.","volume":"12","author":"Johansson","year":"2011","journal-title":"Lancet Oncol"},{"issue":"2","key":"jus180004r38","doi-asserted-by":"publisher","first-page":"120","DOI":"10.7326\/0003-4819-157-2-201207170-00459","article-title":"Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement.","volume":"157","author":"Moyer","year":"2012","journal-title":"Ann Intern Med"},{"issue":"16","key":"jus180004r40","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1503\/cmaj.140703","article-title":"Recommendations on screening for prostate cancer with the prostate-specific antigen test.","volume":"186","author":"Bell","year":"2014","journal-title":"CMAJ"},{"issue":"10","key":"jus180004r41","doi-asserted-by":"publisher","first-page":"761","DOI":"10.7326\/0003-4819-158-10-201305210-00633","article-title":"Screening for prostate cancer: a guidance statement from the Clinical Guidelines Committee of the American College of Physicians.","volume":"158","author":"Qaseem","year":"2013","journal-title":"Ann Intern Med"},{"issue":"2","key":"jus180004r42","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.juro.2013.04.119","article-title":"Early detection of prostate cancer: AUA Guideline.","volume":"190","author":"Carter","year":"2013","journal-title":"J Urol"},{"key":"jus180004r3","volume-title":"Prostate-Specific Antigen\u2013Based Screening for Prostate Cancer: A Systematic Evidence Review for the US Preventive Services Task Force: Evidence Synthesis No. 154","author":"Fenton","year":"2018"},{"key":"jus180004r14","volume-title":"Overview of Prostate Cancer Screening Decision Models: A Contextual Review for the US Preventive Services Task Force","author":"Lin","year":"2018"},{"key":"jus180004r24","volume-title":"Overdiagnosis in Prostate Cancer Screening Decision Models: A Contextual Review for the US Preventive Services Task Force","author":"Petitti","year":"2018"},{"key":"jus180004r1","unstructured":"National Cancer Institute. Cancer stat facts: prostate cancer. https:\/\/seer.cancer.gov\/statfacts\/html\/prost.html. Accessed March 8, 2018."},{"key":"jus180004r20","unstructured":"National Cancer Institute. Genetics of prostate cancer (PDQ\u00ae)\u2013health professional version. https:\/\/www.cancer.gov\/types\/prostate\/hp\/prostate-genetics-pdq. Accessed March 8, 2018."},{"key":"jus180004r22","unstructured":"Centers for Disease Control and Prevention. United States cancer statistics: 1999\u20132014 cancer incidence and mortality data. https:\/\/nccd.cdc.gov\/uscs\/. Accessed March 8, 2018."},{"key":"jus180004r39","unstructured":"American Academy of Family Physicians. Clinical preventive service recommendation: prostate cancer. https:\/\/www.aafp.org\/patient-care\/clinical-recommendations\/all\/prostate-cancer.html. 2012. Accessed March 8, 2018."},{"key":"jus180004r43","unstructured":"American Cancer Society. American Cancer Society recommendations for prostate cancer early detection. https:\/\/www.cancer.org\/cancer\/prostate-cancer\/early-detection\/acs-recommendations.html. 2016. Accessed March 8, 2018."}],"container-title":["JAMA"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/2680553","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,6]],"date-time":"2024-07-06T12:22:40Z","timestamp":1720268560000},"score":1,"resource":{"primary":{"URL":"http:\/\/jama.jamanetwork.com\/article.aspx?doi=10.1001\/jama.2018.3710"}},"subtitle":["US Preventive Services Task Force Recommendation Statement"],"short-title":[],"issued":{"date-parts":[[2018,5,8]]},"references-count":43,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2018,5,8]]}},"URL":"https:\/\/doi.org\/10.1001\/jama.2018.3710","relation":{},"ISSN":["0098-7484"],"issn-type":[{"value":"0098-7484","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5,8]]}}}